Enter your email address to receive updates
Search By Trade Name
Trade name | Generic name | Classification
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z 
Generic Name
Estradiol valerate and Medroxyprogesterone
Trade Name
Risk Category
  • Positive evidence of human fetal risk exists.
  • Potential benefits may warrant use of the drug in pregnant women despite potential risks (e.g. life threatening situations or serious illness).
  • Studies in animals and/or humans have demonstrated fetal abnormalities.
  • Fetal risk involved in use of drug, clearly outweighs potential benefit.
  • Contraindicated in women who are or may become pregnant. Don’t use.
The risk category is D for Medroxy progesterone.
FDA Pregnancy Risk Categories

Place (not click) your mouse cursor over the bold words in the text below to receive description

  • Hormonal replacement therapy.
  • Fetal Risk
    Fetal Risk
  • No well - controlled human data for medroxy progesterone but reported association with cardiovascular defects and ambiguous genitalia.
  • Exposure to estrogens is a possible cause of cardiovascular, eye, ear defects and Down's syndrome.
  • Males exposed in utero to estrogen progesterone may have psychosexual changes (less heterosexual experience fewer musculine interests).
  • Breast Feeding
    Breast Feeding
  • Both excreted into milk and are safe, although estrogens suppress lactation.
  • Other Trade Names
    The information on this Web site is not intended as a substitute for the advice and care of your doctor or other health-care provider. Always consult your doctor if you have any questions about exposures during pregnancy and lactation, and before you take any medications. Please read the Terms and Conditions before using this website.
      Tell A Friend

        Your Friend
     4   +   4    =  
      Calculate Birth Date
    Enter the first day of the last menstruation
    Month Day Year
    Month Day Year